Synthesis and Tritium Labelling of 6β‐Amino‐4,5α‐epoxymorphinans and their 14‐hydroxy derivatives as potential affinity labelling probes with μ opioid agonist activity
暂无分享,去创建一个
S. Lovas | F. Ötvös | S. Hosztafi | G. Tóth | C. Simon
[1] S. Hosztafi,et al. Applicaltion of the Mitsunobu reaction in the morphine series. Preparation of 6β-amino-14β-hydroxymorphine and 14-hydroxycodeine derivatives , 1994 .
[2] S. Hosztafi,et al. Stereoselective synthesis of β-naltrexol, β-naloxol β-naloxamine, β-naltrexamine and related compounds by the application of the mitsunobu reac , 1994 .
[3] S. Hosztafi,et al. Application of the Mitsunobu Reaction for Morphine Compounds. Preparation of 6β-Aminomorphine and Codeine Derivatives , 1992 .
[4] R. Tallarida,et al. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor. , 1990, Molecular pharmacology.
[5] S. Archer,et al. Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone. , 1990, Molecular pharmacology.
[6] L. Liu-Chen,et al. Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine. , 1987, Molecular pharmacology.
[7] P. Portoghese,et al. Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives. , 1987, Journal of medicinal chemistry.
[8] P. Portoghese,et al. Irreversible blockage of opioid receptor types by ester homologues of beta-funaltrexamine. , 1986, Journal of medicinal chemistry.
[9] P. Portoghese,et al. Affinity labels for opioid receptors. , 1985, Annual review of pharmacology and toxicology.
[10] D. L. Larson,et al. IMPORTANCE OF CARBON 6 CHIRALITY IN CONFERRING IRREVERSIBLE OPIOID ANTAGONISM TO NALTREXONE-DERIVED AFFINITY LABELS , 1984 .
[11] D. L. Larson,et al. Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels. , 1983, Journal of medicinal chemistry.
[12] P. Portoghese,et al. Stereospecific synthesis of the 6.alpha.- and 6.beta.-amino derivatives of naltrexone and oxymorphone , 1980 .
[13] D. L. Larson,et al. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. , 1980, Journal of medicinal chemistry.
[14] D. L. Larson,et al. Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity. , 1979, Science.
[15] D. L. Larson,et al. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties. , 1979, Journal of medicinal chemistry.
[16] R. Hanson,et al. Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone. , 1977, Journal of Medicinal Chemistry.
[17] M. Wilchek,et al. [11] Haloacetyl derivatives , 1977 .
[18] G. W. Anderson,et al. A reinvestigation of the mixed carbonic anhydride method of peptide synthesis. , 1967, Journal of the American Chemical Society.
[19] G. W. Anderson,et al. Racemization Control in the Synthesis of Peptides by the Mixed Carbonic-Carboxylic Anhydride Method , 1966 .
[20] J. R. Vaughan,et al. The Preparation of Peptides Using Mixed Carbonic—Carboxylic Acid Anhydrides , 1952 .